Predicting influenza H3N2 vaccine efficacy from evolution of the dominant epitope
We predict vaccine efficacy with a measure of antigenic distance between influenza A(H3N2) and candidate vaccine viruses based on amino acid substitutions in the dominant epitopes. In 2016-2017, our model predicts 19% efficacy compared to 20% observed. This tool assists candidate vaccine selection by predicting human protection against circulating strains.
Code (0)
등록된 구현이 없습니다.
Similar Papers 제목 키워드 기반
Influenza Evolution and H3N2 Vaccine Effectiveness, with Application to the 2014/2015 Season
Influenza A is a serious disease that causes significant morbidity and mortality, and vaccines against the seasonal influenza disease are of variable effectiveness. In this paper, we discuss use of the $p_{\rm epitope}$ …
Prediction of Influenza B Vaccine Effectiveness from Sequence Data
Influenza is a contagious respiratory illness that causes significant human morbidity and mortality, affecting 5-15% of the population in a typical epidemic season. Human influenza epidemics are caused by types A and B, …
Identifying the genetic basis of antigenic change in influenza A(H1N1)
Determining phenotype from genetic data is a fundamental challenge. Influenza A viruses undergo rapid antigenic drift and identification of emerging antigenic variants is critical to the vaccine selection process. Using …
Concepts and methods for predicting viral evolution
The seasonal human influenza virus undergoes rapid evolution, leading to significant changes in circulating viral strains from year to year. These changes are typically driven by adaptive mutations, particularly in the a…
Genomic data analysis in tree spaces
Recently, an elegant approach in phylogenetics was introduced by Billera-Holmes-Vogtmann that allows a systematic comparison of different evolutionary histories using the metric geometry of tree spaces. In many problem s…
Dimensionality Reduction